glp 1 what are they Glucagon-like peptide-1 GLP-1 and Anesthesia: Considerations and
Description
On the basis of results of the most recent CVOTs (DAPA-HF, DAPA-CKD, EMPEROR-R), the FDA has approved dapagliflozin (2020) and empagliflozin (2021) to reduce risk for CV death and HF hospitalization in adults with HF and reduced ejection fraction regardless of whether they have diabetes [24, 25]
10.1038/s41591-024-03374-z
Clinical trials consistently demonstrate GLP-1 agonists produce significant weight loss and improve cardiovascular outcomes in people with obesity or type 2 diabetes
"I trained at the highest level, ate a clean diet, pushed myself, and still, after having kids, my body just wouldnt respond
Of those who had not recently used these medications for weight loss, 6.5% were interested in doing so within the next year
